Status:
COMPLETED
Efficacy of Coordinated Insulin Boluses in Type 1 Diabetic Patients
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A recent study suggests that, in Type 1 Diabetes (T1D) patients treated by insulin pumps, a better coordination of meal boluses and post prandial basal rate could reduce the importance of postprandial...
Eligibility Criteria
Inclusion
- Type 1 diabetes mellitus
- with confirmed Negative C-peptide or diabetes duration\>5 years
- Treated by external insulin pump and rapid insulin analog for more than 3 months
- using a Medtronic Paradigm Real-Time or Veo™ model
- Educated to and practicing functional insulin treatment and carbohydrate counting for more than 3 months
- Able to use the "basal temp" and "glycaemia reminder" functions of their pump
- Basal infusion rate ≥ 0,5 Unit/h
- Self-monitoring of blood glucose frequency \> 4/days
- Aware of hypoglycaemia
Exclusion
- known impaired renal function (creatinin clearance \<60ml/min)
- Gastroparesis
- Serious or instable disease likely to induce a glycaemic control deterioration - treatment with corticosteroids
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2016
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT02229097
Start Date
October 1 2014
End Date
November 1 2016
Last Update
February 23 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Toulouse Rangueil
Toulouse, Haute Garonne, France, 31059
2
Saint-André Hospital
Bordeaux, France, 33000
3
Lapeyronie Hospital
Montpellier, France, 34295